These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9589033

  • 21. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [Abstract] [Full Text] [Related]

  • 22. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.
    Ragnhammar P, Blomgren H.
    Med Oncol; 1995 Sep; 12(3):187-201. PubMed ID: 8852401
    [No Abstract] [Full Text] [Related]

  • 23. Recent advances in the treatment of advanced colorectal cancer.
    Kemeny N, Lokich JJ, Anderson N, Ahlgren JD.
    Cancer; 1993 Jan 01; 71(1):9-18. PubMed ID: 8416731
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin.
    Seiter K, Kemeny N, Martin D, Schneider A, Williams L, Colofiore J, Sawyer R.
    Cancer; 1993 Mar 01; 71(5):1875-81. PubMed ID: 8448752
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer.
    Grem JL.
    Oncology (Williston Park); 2001 Jan 01; 15(1 Suppl 2):13-9. PubMed ID: 11219972
    [Abstract] [Full Text] [Related]

  • 29. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL, McAtee N, Steinberg SM, Hamilton JM, Murphy RF, Drake J, Chisena T, Balis F, Cysyk R, Arbuck SG.
    Cancer Res; 1993 Oct 15; 53(20):4828-36. PubMed ID: 8402669
    [Abstract] [Full Text] [Related]

  • 30. A phase I, II study of high-dose 5-fluorouracil and high-dose leucovorin with low-dose phosphonacetyl-L-aspartic acid in patients with advanced malignancies.
    Ardalan B, Sridhar KS, Benedetto P, Richman S, Waldman S, Morrell L, Feun L, Savaraj N, Fodor M, Livingstone A.
    Cancer; 1991 Sep 15; 68(6):1242-6. PubMed ID: 1873776
    [Abstract] [Full Text] [Related]

  • 31. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG, Benson AB, Catalano P, Rao MS, O'Dwyer PJ, Allegra CJ.
    J Clin Oncol; 2003 Mar 01; 21(5):815-9. PubMed ID: 12610179
    [Abstract] [Full Text] [Related]

  • 32. Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.
    Kemeny NE, Schneider A, Martin DS.
    Cancer Invest; 1990 Mar 01; 8(2):263-4. PubMed ID: 2400946
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW.
    J Clin Oncol; 1989 Oct 01; 7(10):1427-36. PubMed ID: 2789272
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C, Louvet C, de Gramont A, Lucchi E, Seitz JF, Mal F, Raymond E, Cady J, Carola E, Krulik M.
    Cancer; 1997 Mar 15; 79(6):1094-9. PubMed ID: 9070485
    [Abstract] [Full Text] [Related]

  • 39. Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
    Conti JA, Kemeny N, Seiter K, Goker E, Tong W, André M, Ragusa K, Bertino JR.
    J Clin Oncol; 1994 Apr 15; 12(4):695-700. PubMed ID: 7512128
    [Abstract] [Full Text] [Related]

  • 40. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr 15; 13(4):921-8. PubMed ID: 7707120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.